Validation of depression screening scales in patients with CKD
about
A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease.Barriers to successful implementation of care in home haemodialysis (BASIC-HHD):1. Study design, methods and rationale.Screening for depression: only one piece of the puzzle.Impact of sertraline on serum concentration of CRP in hemodialysis patients with depression.Depression and cognitive function in maintenance hemodialysis patients.Association between depressive symptoms and mortality risk in chronic kidney disease.Longitudinal association of depressive symptoms with rapid kidney function decline and adverse clinical renal disease outcomes.Sociodemographic factors contribute to the depressive affect among African Americans with chronic kidney disease.Epidemiology, diagnosis, and management of depression in patients with CKD.Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or deathElevated depressive affect is associated with adverse cardiovascular outcomes among African Americans with chronic kidney disease.Quality of life and psychosocial factors in African Americans with hypertensive chronic kidney disease.Association of depressive and anxiety symptoms with adverse events in Dutch chronic kidney disease patients: a prospective cohort study.Rationale and design of A Trial of Sertraline vs. Cognitive Behavioral Therapy for End-stage Renal Disease Patients with Depression (ASCEND)Factors associated with depressive symptoms and use of antidepressant medications among participants in the Chronic Renal Insufficiency Cohort (CRIC) and Hispanic-CRIC Studies.Association of major depression and mortality in Stage 5 diabetic chronic kidney disease.Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST).Consequences of CKD on Functioning.Neuropsychiatric complications of chronic kidney disease.Gastrointestinal disorders and renal failure: exploring the connection.Association between depression and inflammatory/anti-inflammatory cytokines in chronic kidney disease and end-stage renal disease patients: a review of literature.Prognostic Utility of a Self-Reported Depression Questionnaire versus Clinician-Based Assessment on Renal Outcomes.Cognitive Function and White Matter Changes Associated with Renal Transplantation.Beck Depression Inventory-Fast Screen (BDI-FS): an efficient tool for depression screening in patients with end-stage renal disease.Performance of depression rating scales in patients with chronic kidney disease: an item response theory-based analysis.Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial.Brief cognitive behavioural intervention for depression and anxiety symptoms improves quality of life in chronic haemodialysis patients.Using Problem-solving Therapy to Improve Problem-solving Orientation, Problem-solving Skills and Quality of Life in Older Hemodialysis Patients.Depression in Chronic Kidney Disease and End-Stage Renal Disease: Similarities and Differences in Diagnosis, Epidemiology, and Management.Depression and sexual dysfunction in chronic kidney disease: a narrative review of the evidence in areas of significant unmet need.Association of co-occurring serious mental illness with emergency hospitalization in people with chronic kidney disease.Self-reported Medication Adherence and CKD Progression.
P2860
Q30408395-D2096A04-7F69-42D2-89D7-07FDC73AB393Q31139590-E7096322-DDAB-47B6-8E15-176F0A2AD83EQ33355161-FBC5E672-82F5-4A76-8544-C1C2CCB6A355Q33631013-314E4FA0-212D-4A4E-B8C5-FEB0967D1B41Q34144872-6DED39CC-8F01-4193-BB39-8FDF2A8B3F79Q34349246-D18B4639-B06A-49F9-93DB-4A81D80F98ACQ34751900-435C7F69-EEFB-4060-ADC5-3C511A6D9D2BQ35043608-5A2584AB-6EF9-4F2B-8135-B2BEE27012ABQ35553004-34D64F20-14D7-4B87-B106-7FB6DD9DDFA4Q35553009-201692A4-82BF-4C99-966F-966549C7648FQ35612610-6C23B205-16B7-48FB-AD7A-153A147E144DQ35619199-923B5678-7548-4055-B776-710A195E3FB6Q35782191-7FCC25D8-C888-49C7-9A3A-F802B8707C36Q35856417-A6F95F96-35D6-4CCC-9349-F0770409CC74Q36044295-CAFDF435-EBBE-4AD9-9592-0DCF24E3937EQ36368877-7608CB49-3274-4250-82B0-87850EFD8D03Q36476538-8C606D6C-F26C-4A2F-A09C-2B5E3D5F2D23Q37141165-C003073D-B7DA-476D-9752-17C675757C81Q37766749-6F690AE1-3788-49BF-A179-550C1ED0A37EQ37770400-A6FFA69F-25D3-4C16-B82C-39DF906C5A1DQ38231472-1B85E1D9-B304-4C90-82B1-682E151FB13DQ39424935-C23459A8-739C-4CE6-ACE4-9417D2314C14Q39984215-8794456D-DD9B-4FD1-9E0B-6E787B2093D4Q43654767-06FE1AA9-7971-4940-ADD8-8F57E814E677Q47153905-FD7C51C0-47D1-40FA-BD4E-167857968A4DQ47160609-FFE420D9-1DCE-488B-B14A-3C1B74B33ADFQ47409054-AB1EDD3F-7536-4282-916D-133130324D14Q47569608-DE174452-33A2-4E56-8BB1-E7E6CE8B29E0Q48040943-8A35BA06-5CD0-4382-8B08-F5B259CD87A1Q48224940-F1A7B01D-293D-48C0-A26E-EFF7042C95A8Q50652818-6CF14BBF-BE19-4CDB-8129-3E3F49A4AAFCQ55284951-C92E176E-88E4-46B1-ACA5-B9F15E86D329
P2860
Validation of depression screening scales in patients with CKD
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Validation of depression screening scales in patients with CKD
@ast
Validation of depression screening scales in patients with CKD
@en
type
label
Validation of depression screening scales in patients with CKD
@ast
Validation of depression screening scales in patients with CKD
@en
prefLabel
Validation of depression screening scales in patients with CKD
@ast
Validation of depression screening scales in patients with CKD
@en
P2093
P2860
P1476
Validation of depression screening scales in patients with CKD
@en
P2093
A John Rush
Abu T Minhajuddin
David W Morris
Robert D Toto
S Susan Hedayati
P2860
P304
P356
10.1053/J.AJKD.2009.03.016
P577
2009-06-03T00:00:00Z